## 

## 

|nts|||||||
|---|---|---|---|---|---|---|
|1.|Strategic Report|||||Page|
||o|Highlights<br>ofthe year||||3|
||o|Vision, Mission and Values||||5|
||o|Structure,<br>Governance|and Management|||6|
||o|Report ofthe chair||||9|
||o|Chief Executives Report||||10|
||o|Strategic Priorities for|2020-23|||11|
||o|Risk Management<br>and|Internal||Control|12|
||o|Financial Review||||13|
|2.|Directors Report||||||
||o|Reserves Policy||||16|
||o|Volunteers||||16|
||o|Fundraising||||16|
||o|Executive remuneration||||17|
||o|Investment<br>policy and|objectives|||17|
||o|Our impact on the environment||||17|
||o|Tax status||||18|
||o|Directors responsibilities||statement||18|
||o|Statement ofdisclosure|to auditor|||18|
|3.|Independent<br>auditor's<br>report|||||19|
|4.|Financial<br>Statements|||||23|
|5.|Notes|to the Financial Statements||||26|





## 

## 

## 

## 

|Patient Care||2019/20|2020/21|
|---|---|---|---|
|Number of patients|admitted|380|404|
|Number of patients|discharged|132|162|
|Occupied bed days||5626|5491|
|Outpatient<br>appointments||37|na|
|Lymphedema<br>appointments||1284|1276|
|Advice Line calls||1754|1479|
|Hub patients<br>seen||620|258|



## 



## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 


## 


## 



## 

## 

## 



## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

|Risk Table|202ty21||||
|---|---|---|---|---|
|RiskArea||CHC K<br>Risk||internal|
|||An increased nunster ofstaff have left|the|We have widened the number<br>ofchannels used toadvertise vacanci|
|Shortage ofstaff and||charity and ithas become Increasingly||for staff snd volunteer<br>posts. The number of<br>promotlons<br>have|
|volunteers|across the|4fflcult to recruit replacements.<br>Many||been increased.<br>Fora linfted number ofhard to fill vacandes we have|
|organisation||volunteers 4d not return due to need|to|used recruitment<br>agendes. Our campaigns toattract new volunteers|
|||isolate or care for fsnsly members||through sodal me4a have been successful|
|||||ohsrsdpvtafnhNEtons'fff<br>hefnslntihied<br>ahdtE our tkork, role and phtce|
|||Inconectorspecuh@ve<br>alofyln@e yfESS<br>ehhorekstnttgyor<br>lntefnsayihfohg<br>S.j,<br>changas&servtces,<br>shdf shoitaOas Or<br>idgh sahslea||EiOsflIEEA'hsshh:PfovNSQTkEEEEEIEy.<br>IIISPEihd shdellwES %bs<br>Eff~roflkfyispgss<br>gsk lnhyhfhfs orINEhsf sm Ewea msy<br>~-~~Esd1$. 44ilf.cafnhkdt~<br>here been<br>hhlh~si. 4hlidhijfo sftththffud sulvsytsI the ehecgvensss ofour|
|||||Business requirenwnts<br>have been scoped and potential<br>options|
|||NHS organisstlon<br>and organisations<br>that||identified.<br>Apreferred solution has been chosen and coatings agreed.|
|Electronic patient records||deliver care under NHS contract are<br>required to have electronic records by|the|However, as at Februaty<br>2020we have no dearsteerfromlocal<br>consrtssloners<br>snd other providers<br>about their choice ofsystem|
|||end of2020.||Covid has delayed the 2020dea4ine. Eprescribing has been|
|Insane gansrsgon||||prloritised<br>at CHC and went live at both units during June 2021.<br>Ihilso lkkgt lsdoina gssetsgnj~oIEywlthtn ssih guldegnes<br>mily,'EI~ hhthns forfhvdichd seyyoft svsgshie under<br>4'+eifiitNitsfldoofnvEE<br>Couhto scheinaa, Revtsw<br>sisfullysg|
|||||skpesigturL<br>IIEEesIohsftfskss 0Issfrosoit.|
|||Consultant<br>delivered spedalist<br>palliative||Service Review positive snd the former Me4cal Director wss|
|||care in reach service being paoted with||supporting<br>RCHT In development<br>ofbusiness case for more|
|Clinical||RCHT. Informal agreement<br>during pllotand||consultant<br>capadty across all care settings<br>in in the county.|
|||potential<br>rdsmateh ofexpectations<br>could||Agreement<br>reached totransler<br>CHC consultant<br>resource to RCHT I|
|||lead to reputstionsl<br>risk.||CF7in mid 2021.|



## 

## 



## 

|Financial Summary f0005|Financial Summary f0005|Financial Summary f0005|2020/21<br>Actual|2020/21<br>Budget|2019/20<br>Actual|
|---|---|---|---|---|---|
|Total Income|||9,669.6|11,212.6|10,313.6|
|Expenditure|||10,141.9|11,508.0|10,978.4|
|Operating<br>Result|||-472.3|-295.4|-664.8|
|Gain / lloss) on investments||&pro|406.3|22.0|-182.1|
|Gain / lloss) on disposal|of|fixed a|1.3|0.0|2.6|
|Gain / lLoss) on pension|scheme p||16.0|0.0|-14.8|
|Surplus / deficit|||~.8|-273.4|-859.2|



## 

|Income Summary f0005|2020/21<br>Actual|2020/21<br>Budget|2019/20<br>Actual|
|---|---|---|---|
|Legacies|1,674.5|2,433.6|1,433.4|
|Donations|540.8|410.6|429.8|
|Fundraising|498.1|993.3|820.3|
|Gross income from Retail|1,282.4|5,220.8|4,955.6|
|Gross income from Lottery|678.0|736.5|680.0|
|Income from clinical contracts|1,444.8|1,044.8|1,172.5|
|Covid 19Grants|3,248.7|0.0|487.1|
|Investment<br>Income|121.2|69.5|106.8|
|All other income|181.1|303.5|228.1|
|Total Income|9,669.6|11,212.6|10,313.6|





## 

|Expenditure|Summary f0005|2020/21<br>Actual|2020/21<br>Budget|2019/20<br>Actual|
|---|---|---|---|---|
|Retail||3,265.5|4,083.4|4,113.0|
|Lottery||195.5|329.3|292.9|
|Cost of raising funds||472.9|534.6|562.3|
|Provision ofcare||6,105.4|6,440.6|5,914.4|
|Support costs||102.6|120.1|95.8|





## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

|Consolidated<br>statement|Consolidated<br>statement|Consolidated<br>statement|offinanci|al<br>activitie|s||||
|---|---|---|---|---|---|---|---|---|
|For the year ended 31March|||202/||||||
||||||Unrestricted|Restricted|Total|Total|
||||||funds|funds|2021|2020|
|||||Notes|||||
|Income|||||||||
|Donations<br>8t; legacies|||||2,215,283||2,215,283|1,863,218|
|Income from Charitable|Activities||||1,444,792||1,444,792|1,172,503|
|Income from Other Trading|||Activities:||||||
|Commercial<br>trading<br>operations|||||1,960,435||1,960,435|5,635,616|
|Fundraising|||||488,066|10,000|498,066|820,286|
|Covid-19 support<br>income|||||1,317,449|1,931,295|3,248,744|487,041|
|Other income|||||181,072||181,072|228,072|
|Investment<br>income|||||121,192||121,192|106,821|
|Total Income|||||7,728,289|1,941,295|9,669,584|10,313,557|
|Expenditure|||||||||
|Expenditure<br>on raising|funds||||||||
|Commercial<br>trading<br>activities|||||3,460,993||3,460,993|4,405,925|
|Costs ofgenerating<br>donations|||and legacies||451,786||451,786|539,935|
|Investment<br>portfolio fees|||||21,126||21,126|22,357|
|Expenditure<br>on charitable||activities|||||||
|Provision ofcare|||||4,154,248|1,951,083|6,105,331|5,914,388|
|Support costs|||||102,629||102,629|95,822|
|Total Expenditure|||||8,190,782|1,951,083|10,141,865|10,978,427|
|Net gains/(losses)<br>on investments|||||406,319||406,319|(182,076)|
|Net expenditure|||||(56,174)|(9,788)|(65,962)|(846,946)|
|Transfers|||||||||
|Gross transfers between|funds||||||||
|Other recognised<br>gains|and|losses|||||||
|Gain on disposal offixed assets|||||1,240||1,240|2,637|
|Pension Liability|||||15,966||15,966|(14,822)|
|Net movement<br>in funds|||||(38,968)|(9,788)|(48,756)|(859,131)|
|Reconciliation<br>offunds:|||||||||
|Fund balances brought<br>forward|||||8,374,369|759,986|9,134,355|9,993,486|
|Fund balances carried|forward|||27,28,29|8,335,401|750,198|9,085,599|9,134,355|





## 

## 

|As at 31M|a|rch 202|1||||||
|---|---|---|---|---|---|---|---|---|
||||||The|The|The|The|
||||||Company|Group|Company|Group|
||||||2021|2021|2020|2020|
|||||Notes|||||
|Fixed assets|||||||||
|Tangible assets||||18,19|4406,744|4406,744|4,430,588|4,430,588|
|Intangible|assets|||20||||4,139|
|Investments||||21|3,611,643|3,611,643|3,405,080|3,405,080|
||||||7,918,387|7,918487|7,835,673|7,839,807|
|Current assets|||||||||
|Stock||||22|20,979|104,029|20,979|105,366|
|Debtors||||23|1495,430|1,098,545|1,607,707|1,500,835|
|Cash at bank||and in|hand||340,101|603,711|121,789|402,229|
||||||1,656,510|1,806,285|1,750,475|2,008,430|
|Creditors:||amounts|falling due within||||||
|one year|||||(549,858)|(639,073)|(890,933)|(713,882)|
|Net current||assets|||1,106,652|1,167,212|859,542|1,294,548|
|Provision|for liabilities||||||||
|Total net assets|||||9,025,039|9,085,599|8,695,215|9,134,355|
|The funds|ofthe charity||||||||
|Restricted funds||||27|750,198|750,198|759,986|759,986|
|Unrestricted||funds||28|8474,841|8435,401|7,935,229|8,374,369|
||||||9,025,039|9,085,599|8,695,215|9,134,355|





## 

## 

|For the year ended 31March 2021|||||||
|---|---|---|---|---|---|---|
|||Note||2021||2020|
|Cash provided<br>by/(used<br>in)|||||||
|operating<br>activities||34||44,937||(947,002)|
|Cash flows from investing<br>activities|||||||
|Interest income|||198||1,861||
|Dividends<br>income|||61,580||74,593||
|Rental income from investment<br>property|||59,414||30,367||
|||||121,192||106,821|
|Purchase oftangible fixed assets|||(173,042)||(177,919)||
|Purchase ofinvestments|||(634,155)||(580,270)||
|Receipts from sale ofinvestments|||833,916||537,595||
|Withdrawal<br>offunds from Investment|Portfolio||||139,500||
|Receipts from sale oftangible fixed assets|||8,634||1,707||
|Net cash flows from investing<br>activities||||35,353||(79,387)|
|Increase/(decrease)<br>in cash equivalents||||201,482||(919,568)|
|Cash and cash equivalents<br>at 1April|2020|||402,229||1,321,797|
|Cash and cash equivalents<br>at 31March 2021||||603,711||402,229|





## 

## 

## 

## 

## 

## 

## 

## 

## 

|Tangible fixed assets and depreciation||||||||
|---|---|---|---|---|---|---|---|
|Individual<br>fixed assets costing /500 or|more are capitalised<br>at cost and are depreciated|||over|their estimated||useful|
|economic lives on a straight<br>line basis as follows:||||||||
|Freehold buildings|2%per annum|at cost|(minor|refurbishment||costs|100%)|
|Short leasehold<br>improvements|over the period|ofthe|lease|||||
|Long leasehold<br>buildings|2%per annum|(minor|refurbishment||costs|100%)||
|Medical equipment<br>and fittings|10%per annum|||||||
|I.T.equipment|15% - 25%per|annum|on cost|||||
|General equipment<br>and fittings|10%- 100%per annum|||||||
|Motor vehicles|20%per annum|||||||
|Depreciation<br>is calculated on a monthly|basis where assets are purchased|during|the year.|||||





## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

|Donations<br>and Legacies|||
|---|---|---|
||2021|2020|
|Legacies|1,674,488|1,433,383|
|Donations|540,795|429,835|
||2,215,283|1,863,218|





## 

|6|Income from trading|activities|||
|---|---|---|---|---|
||Commercial<br>operations||||
||||2021|2020|
||Gross Income Irom shops||1,282,414|4,955,568|
||Gross Income Irom Lottery||678,021|680,048|
||||1,960,435|5,635,616|
||Fundraising||||
||||2021|2020|
||Trusts and grants||84,258|121,651|
||Fundraising<br>activities||413,808|698,635|
||||498,066|820,286|
|7|Covid-19 support grant income||||
||||Group|Group|
||||2021|2020|
||Grant income &om NHS England||1,931,295||
||Job Retention Scheme|grant income|987,903||
||Local Authority<br>grant|income|329,546|487,041|
||||3,248,744|487,041|
|8|Investment<br>income||||
||||Group|Group|
||||2021|2020|
||Property||59,414|30,367|
||Bank interest||198|1,861|
||Listed investments||61,580|74,593|
||||121,192|106,821|





## 

## 

## 

|9<br>Total expendit|ur|e<br>-group|||||||
|---|---|---|---|---|---|---|---|---|
||||||Commercial||||
||||Provision|Raising|trading|Support|2021|2020|
||||ofcare|funds|expenses|costs|Total|Total|
|Staffcosts|||5,332,722|326,253|2,015,557|45,795|7,720,327|7,623,730|
|Patient care|||32,070||||32,070|79,914|
|Medical supplies &drugs|||104,610||||104,610|98,491|
|Catering &domestic|supplies||64,838||||64,838|78,257|
|Travel expenses|||15,077||||15,077|40,249|
|Training &education|||33,220||||33,220|50,680|
|Laundry|||7,188||||7,188|16,980|
|Electricity &Gas|||51,711||||51,711|46,547|
|Telephone|||47,108||||47,108|48,928|
|Rates and water|||19,610||||19,610|16,824|
|Uniforms|||2,921||||2,921|8,452|
|Printing,<br>Postage and|stationery||28,108||7,810||35,918|36,349|
|Insurance|||27,336||||27,336|28,114|
|Repairs and maintenance|||102,887||||102,887|117,368|
|Depreciation|||147,430||127,990||275,420|293,063|
|Direct fundraising<br>costs||||34,570|||34,570|128,595|
|Department<br>fundraising||costs||67,753|||67,753|76,496|
|Banking charges||||5,730|10,682||16,412|12,234|
|Administration<br>charge|||88,495|8,374|70,258||167,127|227,490|
|Audit and accountancy||||||15,146|15,146|14,505|
|Legal and professional||fees||||41,688|41,688|39,574|
|Irrecoverable<br>VAT||||9,105|||9,105|9,472|
|Cost ofsales|||||152,368||152,368|509,524|
|Shops operating<br>expenses|||||1,057,468||1,057,468|1,331,396|
|Investment<br>portfolio fees||||21,127|||21,127|22,357|
|Staffrelocation &recruitment|||||18,860||18,860|22,838|
||||6,105,331|472,912|3,460,993|102,629|10,141,865|10,978,427|





## 

## 

## 

|charitable<br>activity. Their|deta|il along with basis o|fapportionment<br>is shown|in the table below:||
|---|---|---|---|---|---|
||||Governance|Basis ofapportionment||
||||function|||
|Staffcosts|||35,066|Key management<br>allocated on time||
|Audit and accountancy|||15,146|Governance||
|Legal and professional|||41,689|Governance||
||||91,901|||
|Net expenditure<br>for the|year|||||
|This is stated after charging||the following:||||
|||||2021|2020|
|Auditors'<br>remuneration|—audit (group)|||15,146|14,505|
|Operating<br>leases||||661,460|680,361|
|Depreciation<br>(group)||||289,487|293,063|
|Amortisation<br>(group)||||4,139|4,139|



|||2021|2020|
|---|---|---|---|
|Staff and management||269|300|
|The aggregate|payroll costs ofthese persons were as follows:|||
|||2021|2020|
|Wages and|salaries|6,520,065|6,592,307|
|Social security costs||533,531|546,571|
|Other pension costs||510,866|459,852|
|Termination|payments|155,865|25,000|
|||7,720,327|7,623,730|





## 

|ine employees<br>had annualised<br>emolume|nts<br>for the yea|r in excess|off60,000 and fell i|nto the following ba|nds:|
|---|---|---|---|---|---|
|||||2021|2020|
|f60,000to f70,000 —Director ofClinical Services, 3||Consultants,|Head ofHR|||
|f70,000to f80,000 —Finance Director,|1 x Consultant,|1 x Speciality Doctor||||
|f80,000to f90,000||||||
|f90,000to f100,000 —Chief Executive||||||
|f100,000to f,110,000||||||
|f110,000to K120,000||||||



## 

## 

## 



## 

## 

## 

|A summary of|the r|esults oft|he subsidiaries<br>is sh|own below:||||
|---|---|---|---|---|---|---|---|
||||Cornwall|Cornwall|Resource|||
||||Hospice Care|Hospice Care|Kernow|||
||||Trading|Lottery|Newco|Total|Total|
||||Limited|Limited|Ltd|2021|2020|
|Per company accounts||||||||
|Turnover|||81,742|678,021||759,763|1,213,489|
|Cost ofsales|||(49,966)|(102,401)||(152,367)|(506,059)|
|Interest payable||||||||
|Administrative|expenses||(31,127)|(90,730)||(121,857)|(268,979)|
|Interest receivable|||14|||14|690|
||||663|484,890||485,553|438,141|
|Amount<br>distributed||to the||||||
|charity via Gift|Aid||(61,178)|(802,963)||(864,141)|(440,742)|
|Result in the subsidiary|||(60,515)|(318,073)||(378,588)|(2,601)|
|The assets and liabilities ofthe subsidiaries<br>were:||||||||
|||||Cornwall|Cornwall|Resource||
|||||Hospice Care|Hospice Care|Kernow||
|||||Trading|Lottery|Newco|Total|
|||||Limited|Limited|Ltd|2021|
|Per company<br>accounts||||||||
|Current assets||||190,494|157,171|1|347,666|
|Current<br>liabilities||||(189,827)|(97,280)||(287,107)|
|Total net assets||||667|59,891||60,559|
|Aggregate<br>share capital and reserves||||667|59,891||60,559|





## 

|||||Total|Total|
|---|---|---|---|---|---|
|||||2021|2020|
|Income||||9,391,720|9,160,409|
|Gift aid from subsidiaries||||864,141|440,742|
|||||10,255,861|9,601,151|
|Expenditure|on charitable||activities|9,926,037|10,458,677|
|Net income/(expenditure)||||329,824|(857,526)|
|Total funds brought||forward||8,695,215|9,552,741|
|Total funds|carried|forward||9,025,039|8,695,215|
|Represented|by:|||||
|Restricted funds||||750,198|759,986|
|Unrestricted|funds|||8,274,841|7,935,229|
|Total funds|carried|forward||9,025,039|8,695,215|





## 

## 

|Consolidated||||||||
|---|---|---|---|---|---|---|---|
||||||Unrestricted|Restricted|Total|
||||||funds|funds|2020|
|Income||||||||
|Donations k legacies|||||1,863,218||1,863,218|
|Income &om Charitable|Activities||||1,172,503||1,172,503|
|Income from Other Trading|||Activities:|||||
|Commercial<br>trading operations|||||5,635,616||5,635,616|
|Fundraising|||||771,030|49,256|820,286|
|Covid-19 support income|||||487,041||487,041|
|Other income|||||228,072||228,072|
|Investment<br>income|||||106,821||106,82|
|Total Income|||||10,264,301|49,256|10813,557|
|Expenditure||||||||
|Expenditure<br>on raising|funds|||||||
|Commercial<br>trading<br>activities|||||4,405,925||4,405,925|
|Costs ofgenerating<br>donations|||and legacies||539,935||539,935|
|Investment<br>portfolio fees|||||22,357||22,357|
|Expenditure<br>on charitable||activities||||||
|Provision ofcare|||||5,845,594|68,794|5,914,388|
|Support costs|||||95,822||95,822|
|Total Expenditure|||||10,909,633|68,794|10,978,427|
|Net losses on investments|||||(182,076)||(182,076)|
|Net expenditure|||||(827,408)|(19,538)|(846,946)|
|Transfers||||||||
|Gross transfers between|funds|||||||
|Other recognised<br>gains|and|losses||||||
|Gain on disposal offixed assets|||||2,637||2,637|
|Costs payable re pension|contributions|||adjustment|(14,822)||(14,822)|
|Net movement<br>in funds|||||(839,593)|(19,538)|(859,131)|
|Reconciliation<br>offunds:||||||||
|Fund balances brought<br>forward|||||9,213,962|799,524|9,993,486|
|Fund balances carried forward|||||8,374,369|759,986|9,134/55|





||||cd0|||OO|O <br>C|O<br> g|Ch<br>QO||en<br>QO<br>Pl<br>I|I<br>OO<br>OO|Vt|Ch<br>O||QO<br>OO<br>lentO||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||QO|||QO|||||||||
|||0<br>4I8<br>~~ <br>0 <br>Cl'|dt<br>at<br> 0<br> M<br>~|CIA||Ch<br>LD<br>OO<br>Ch<br>C4|QO||||||||Vt<br>c<br>Vt<br>Vl|O|IJ<br>Ott<br>Clt<br>p<br>'5|
||||||||||||||||||p|
|||O<br>o <br>g|Ctt<br>4I<br> .h<br> Z|||aQOO<br>Ch<br>I<br>QO M|||||Ch|M<br>QO|'lA|plO|VI<br>Vl||af<br>p<br>S4<br>4I<br>Ct|
||||||||||||||||||p|
||||||||||||||||||p|
|||dt|dc||||QO||Ch||lA|QO|||Ch<br>Ch|ChO|p|
||||||||||ChO||lA|||||||
|||||||QO||||||||||||
|||i4||||||||||||||||
||||||||||||||||||O|
||Cfl|0<br>cd|4)<br> 0|||OOO<br>O|QO<br>Ch<br>QO||O||Ol<br>OO|LD<br>lA||O<br>Ch||lA<br>QO|O<br>O|
||||Ctl8|||||||||||||||
||||||||||||||||||p|
|||0<br>ce<br>0|ctt|II4||O<br>QO|I|I|O<br>QO|||||QO|00<br>VI<br>00|lA<br>C<br>CII|pp<br>cd0<br>cd|
|0<br>cd||4I|C|||lA|||lA|||||CV|||4I|
|0480|||Po||||||||||||||O|
||||||||||||||||||Ott|
|cd'0||||||O|||O|||w|Clt<br>p<br>Q||co|O|Ct|
|IK<br>NI0<br>cd|||||cd <br>IO|O<br> 4|cd0|al<br>rnpS4<br>c/0|O|g|O|I|0<br>P<br>M|o|cd|O|Ct<br>p|
|||||||||||||U|Ccl||||III|





|||cd<br>O|||QOO<br>t|QOO<br>t|O<br>cc,|CtI<br>00||ccI<br>I<br>00<br>QO<br>WO<br>00<br>t|ccI<br>I<br>00<br>QO<br>WO<br>00<br>t|vl"|Ctc<br>CI<br>QOO|t<br>O|00<br>00||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||QO|||00||||||'ct|||
||g|cd||||00|||||'ct<br>Oc|I|t<br>QO|ctl<br>c<br>VI|00|V<br>OII|
|||||||||||||||IA|cD||
||~~<br>P|O<br> M|||||||||||Cd|||V|
||CI'|~|||||||||||||||
|||||||||||||||||0|
|||||||QO|O|||||||||aI0|
||||||||Ch||||QO||||||
||g|2||||||||||||||S4<br>ILI00|
|||||||||||||||||V|
|||||||QO||CtI|||QO||Ccc|OI<br>Ch|Oc<br>cD|0|
||CQ<br>@II|Pg|||m<br>00|||Ql<br>CtI|||||QO<br>Oc|'ct|LO|cD<br>CI|
||O'|~8|||||||||||||||
|O|O|4 <br>C|w||00|QO<br>Ccc||CI|||||lA|00<br>Oc||CI|
|Cn|V||||O|QO||CI|||||cD|cO<br>Ctc||cD|
|||O|||||||||||||||
|||C4|||||||||||||||
|||||||||||||||||0|
||CI<br>g<br>cd|w<br>Oa<br>O||||||||||I|QO|00<br>Vl<br>'ct|lAt<br>IVI|0V<br>QI'0|
||O||||cD<br>00|||QO|||I|||00|Cht|ccl|
||||||EA||||||||||||
|||||||||||||||||V'0|
|||Fa||||||||||||||V|
|||||||||||||||||OII|
|||||||||||||ac|||||
||||||||||||cd|0|||O||
|||||.& O<br>&O<br>4 cv<br>o4<br>%4||Mg|cd<br>M0||g <br>.Cd <br>a|cD<br> O<br> 'C|w|g<br>aD<br>0<br>V<br>QI<br>ccI||cO<br>V|ID<br>V|cdO<br>cd<br>00|
||||||||ac||||cd<br>UR<br>V|||||VV|





## 

## 

## 

||Goodwill||Total||||
|---|---|---|---|---|---|---|
|Costor valuation|||||||
|At 1 April 2020|12,417||12,417||||
|Additions|||||||
|Disposals|||||||
|At 31 March 2021|12,417||12,417||||
|Depreciation|||||||
|At 1 April 2020|8,278||8,278||||
|Charge for the year|4,139||4,139||||
|Released on disposal|||||||
|At 31 March 2021|12,417||12,417||||
|Net book value|||||||
|At 31March 2021|||||||
|At 31March 2020|4,139||4,139||||
|Investments|||||||
||Freehold|Investment|in||||
||investment|subsidiary||Investment|Company|Group|
||property|undertakings||portfolio|2021|2021|
|||||||K|
|At 1 April 2020|516,641|||2,888,439|3,405,085|3,405,085|
|Additions<br>at cost||||634,155|634,155|634,155|
|Disposals||||(833,916)|(833,916)|(833,916)|
|Unrealised<br>gains/(losses)||||406,025|406,025|406,025|
|Realised gains/(losses)||||294|294|294|
|At 31March 2021|516,641|||3,094,997|3,611,643|3,611,643|



## 



## 

## 

|22|Stocks|||||||
|---|---|---|---|---|---|---|---|
|||||Company|Group|Company|Group|
|||||2021|2021|2020|2020|
||Goods for resale|||12,079|95,129|12,079|96,466|
||Drugs, medical supplies etc.|||8,500|8,500|8,500|8,500|
||Maintenance|stocks||400|400|400|400|
|||||20,979|104,029|20,979|105,366|
|23|Debtors|||||||
|||||Company|Group|Company|Group|
|||||2021|2021|2020|2020|
||Recoverable|income|tax|||51,130|51,130|
||VAT recoverable|||50,967|49,778|73,999|63,697|
||Amounts<br>owed by group undertakings|||196,701||98,314||
||Other debtors|||51,814|52,819|48,658|48,658|
||Prepayments|and accrued income||995,948|995,948|1,335,606|1,337,350|
|||||1,295,430|1,098,545|1,607,707|1,500,835|
|24|Creditors:<br>amounts||falling due within one year|||||
|||||Company|Group|Company|Group|
|||||2021|2021|2020|2020|
||Trade creditors|||138,557|141,107|134,574|147,837|
||Other creditors|||98,068|98,280|215,752|220,001|
||Other taxation|and social security||135,893|135,775|136,652|137,577|
||Amounts<br>owed to group undertakings|||||298,990||
||Accruals|||166,660|182,617|94,706|129,258|
||Deferred income (note 25)|||10,680|81,294|10,259|79,209|
|||||549,858|639,073|890,933|713,882|





## 

## 


## 

## 




||||||||||||||I||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|CJ|||||||||||LD|LO|||
|O|||||||QO|||||00||IA|
||||||||||||C||||
||||||||QO||||QO|||QO|
||||||Ch<br>C<br>QO<br>CO|00|O|I<br>I<br>I<br>I|||CV<br>CV<br>O|CV|O||
|||||||||I|||||||
|||||||||I|||||||
|||||||||I|||||||
|||||||||I|||||||
|||||||||I|||||||
|||||||||I|||||||
|Q|g|||O||O<br>LA||I<br>I<br>I<br>I|||OO<br>lA||O<br>lA||
|||||||||I|||LO||LD||
|||||||||I|||||||
|||||||||I|||||||
|||||||||I|||||||
|||||||||I|||||||
|||||||||I|||||||
|||C4|M||||Ch|'8|||||||
|||O|||||||||O||||
|||4||||||'CI|||W|oo|||
|||||||||CC|||||||
|||||||||CQ|||||||
|||||||V1||4||Ck|||||
|||||||lA||I|O||||||
|||||||||I|||||||
|||||||O||I<br>I|CC|rn4)|||O||
|||||||||I|CC||||||
|||||||||I|||||||
|||||||||I|||||||
|||||||||I|||||||
|||||||||I|||||||
|||||||||I|||||||
|||||||||I|||||||
|||||||||I|||||||
|ce|C<br> &|||O||V1O|W<br>'LO<br>V)<br>Vl|I<br>I<br>I<br>I<br>I<br>I||||||IA<br>Ill<br>IA|
|||||||||I|||||||
|||||||||I|||||||
|||||||||I|||||||
|||||||||I|||||||
||||||ct5|||||||ittV|||
||||||Cl||||||||||
|||||||||||||V|||
|||||O<br>O|~Oj<br>B||||||O|~O<br>III|||
||||||||CC||||||||
||||||O||||||||||
||||||4||||||||||





||||C||CII||||ID|Ch||Ch<br>ICI|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||CV||||||||||
|||||||||||||C|
|||||||||||QO|||
||||QO|||||||||QO|
|||||||I|||||||
|||||||I|||||QO||
|||||CQ||I|||C&||||
|||||CO||I|||||||
|||||lA||I<br>I|||QO||||
|||||||I|||||||
|||||||I|||||||
|||||||I|||||||
|||||||I|||||||
|||||||I|||||||
|||||||I|||||||
|O|||||C&|I||||||C&|
|||||ICI|CQ|I<br>I||||||C&<br>lA|
|||||||I|||||||
||Cl|||lA||I||||||V&|
|||||||I|||||||
|||||||I|||||||
|||||||I|||||||
|||||||III'e|||||||
|||4<br>O||||C||4~|||I||
|||||||4l|||||||
|||A||||CCM||A||Ch|||
|||||||A|||||||
|C<br>CQ <br>~a<br>al|Ck<br> )<br>LQ|||||I<br>I<br>I<br>I<br>I|C||||||
||4k|||||I|||||||
|||||||I|||||||
|||||||I|||||||
|||||||I|||||||
|||||||I|||||||
|||||||I|||||||
|||||||I|||||||
|||||||I|||||||
|||||||I|||||||
|P4<br>C<br>C<br>4g|||Ch<br>QO|||I<br>I<br>I<br>I||||I|QO|C<br>'CP|
|||||||I||||||C|
|||||||I||||||'LO|
|||||||I|||||||
|||||||I|||||||
|||||||||||v5|||
|||||||4||||~O||C&|
||||||O|IO|||Ch<br>o <br>'g|O<br>4OA||C&<br>O|





## 

## 

## 

## 

||||Unrestricted|Restricted|Total|
|---|---|---|---|---|---|
||||funds|funds||
|Fixed assets|||3,556,546|750,198|4,306,744|
|Investments|||3,611,643||3,611,643|
|Current assets|||1,806,285||1,806,285|
|Current liabilities|||(639,073)||(639,073)|
||||8,335,401|750,198|9,085,599|
|Consolidated|fund balances at 31March 2020 are represented|by:||||
||||Unrestricted|Restricted|Total|
||||funds|funds||
|Fixed assets|||3,674,741|759,986|4,434,727|
|Investments|||3,405,080||3,405,080|
|Current assets|||2,008,430||2,008,430|
|Current liabilities|||(713,882)||(713,882)|
||||8,374,369|759,986|9,134,355|





## 

## 

||||Land &buildings|Land &buildings|Land &buildings|Land &buildings|
|---|---|---|---|---|---|---|
||||Company|Group|Company|Group|
||||2021|2021|2020|2020|
|Expiring|within|1 year|415,424|415,424|395,116|395,116|
|Expiring|2 - 5 years||982,585|982,585|937,807|937,807|
|Expiring|in more|than five years|375,313|375,313|340,033|340,033|
||||1,773,322|1,773,322|1,672,956|1,672,956|
||||Other||Other||
||||Company|Group|Company|Group|
||||2021|2021|2020|2020|
|Expiring|within|I year|45,725|45,725|45,725|45,725|
|Expiring|2-5 years||2,638|2,638|40,844|40,844|
||||48,363|48,363|86,569|86,569|



## 

## 

## 



## 

## 

||||||2021|2020|
|---|---|---|---|---|---|---|
|Net expenditure<br>per|statement|offinancial|activities||(48,756)|(859,131)|
|(Gains)/losses<br>on investments|||||(406,319)|182,076|
|Investment<br>income|||||(121,192)|(106,821)|
|Less profit on sale ofassets|||||(1,240)|(2,637)|
|Add back depreciation<br>charge|||||293,626|297,202|
|Decrease in stocks|||||1,337|72,666|
|Decrease in debtors|||||402,290|(539,688)|
|(Decrease)/increase|in creditors||||(74,809)|9,331|
|Net cash provided|by/(used|in) operating|activities||44,937|(947,002)|
|Analysis ofnet debt|||||||
|||||1 April 2020|Cash flows|31March|
|||||||2021|
|Cash at bank and in|hand|||402,229|201,482|603,711|



